Opinion: Reducing Whistleblower Risk

It takes significant time and money for a scientist to defend his or her accusation of research misconduct.

Written byHelene Z. Hill
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, STEAKPINBALLAs an unsuccessful whistleblower, I know first-hand that the system to deal with misconduct in science often fails. Details of my 14-year odyssey are on my website and in a November 2013 Nature article. I advocate that, to minimize scientific misconduct, we establish a better system for reporting and adjudicating it.

My story started when I witnessed what I believed—and were supported by a second observer to be—data fabrication. In short, numbers were recorded for samples that we believed did not exist. I followed the guidelines promulgated by my university for reporting perceived misconduct as closely as I could. I was referred to the Campus Committee on Research Integrity (CCRI), a standing committee of representatives of the various schools on the Newark campus of the University of Medicine and Dentistry of New Jersey of which my employer, the New Jersey Medical School, was a part. Nine individuals sat on the CCRI. Some were administrators; there was a nurse, a midwife, a lawyer, and the vice president for research—none of whom had any expertise in the research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies